Vicryl rapide - Polyglactin 910 suture

Overview

Coated Vicryl Rapide Suture is a synthetic absorbable sterile surgical suture composed of a copolymer made from 90% glycolide and 10% L-lactide.
Although this suture is a synthetic absorbable suture, its performance characteristics are intended to model the performance of collagen (surgical gut) suture.
Coated Vicryl RapideE Suture is indicated only for use in superficial soft tissue approximation of the skin and mucosa, where only short term wound support (7-10 days) is required. Coated Vicryl Rapide Suture is not intended for use in ligation, ophthalmic, cardiovascular or neurological procedures.

Description

Vicryl Rapide Suture is indicated only for use in superficial soft tissue approximation of the skin and mucosa, where only short term wound support (7-10 days) is required. Coated Vicryl Rapide Suture is not intended for use in ligation, ophthalmic, cardiovascular or neurological procedures.
Vicryl Rapide Suture, when used in closure of skin and mucous membranes, typically begins to fall off 7-10 days post-operatively and can be wiped off subsequently with sterile gauze.
Progressive loss of tensile strength and eventual absorption of Vicryl Rapide Suture Suture occurs by means of hydrolysis. Absorption begins as a loss of tensile strength followed by a loss of mass.

Specifications

Suture Construction: Braided
Suture Color: White (undyed)
Available Sizes: 8/0 through 1
Suture BSR Profile (BSR=breaking strength retention (tensile strength of suture in vivo)): 5 days 50% / 14 days 0%
Absorption complete by: 42 days

Monocryl - Polyglecaprone 25 suture

Overview

Monocryl Sutures is a monofilament synthetic absorbable surgical suture prepared from a copolymer of glycolide and epsilon-caprolactone.
Monocryl Sutures are indicated for use in general soft tissue approximation and/or ligation, but not for use in cardiovascular or neurological tissues, microsurgery or ophthalmic surgery

Description

Monocryl Suture is indicated for use in general soft tissue approximation and/ or ligation, but not for use in cardiovascular or neurological tissues, microsurgery, or ophthalmic surgery.
This suture, being absorbable, should not be used where extended approximation of tissue under stress is required, such as in fascia.
Progressive loss of tensile strength and eventual absorption of Monocryl Suture occurs by means of hydrolysis. Absorption begins as a loss of tensile strength followed by a loss of mass

Specifications

Suture Construction: Monofilament
Suture Color: Violet / Clear (undyed)
Available Sizes: 6/0 through 1
Suture BSR Profile (BSR=breaking strength retention (tensile strength of suture in vivo)):
Undyed (clear)           Dyed (violet)
1 week 50-60%                   60-70%
2 week 20-30%                 30-40%
Absorption complete by: 91-119 days

Monocryl Plus - Polyglecaprone 25 antibacterial suture

Overview

Secure skin closure is an integral step of nearly every surgical procedure. If the closure device does not provide the strength and support required by the skin tissue, the wound edges may separate, providing a potential pathway for bacterial contamination, which can lead to infection and suboptimal cosmesis.
To create an environment that facilitates healing of the skin tissue, sutures should:
Provide the support necessary to maintain wound-edge approximation during the critical healing period (5-7 days after surgery).
Protect against colonization of the suture by organisms commonly associated with SSIs.
Pass smoothly through fascia to minimize tissue trauma
Monocryl Plus Sutures are ideal for subcuticular skin closure.
High initial breaking strength to maintain wound approximation during the critical first few days of skin healing.
Shown in vitro to kill bacteria and inhibit bacterial colonization of the suture.
Monofilament design and polymer properties minimize drag force and elicit only a slight tissue reaction during absorption.

Description

Monocryl Plus Sutures offer unique benefits for skin tissue, including:
Wound-holding strength required to support tissue during the critical healing period (5 to 7 days). Protection against colonization of the suture by bacteria commonly associated with SSIs, including:
Staphylococcus aureus
Staphylococcus epidermidis
Methicillin-resistant Staphylococcus aureus (MRSA)
Methicillin-resistant Staphylococcus epidermidis (MRSE)
Klebsiella pneumoniae
Escherichia coli
Minimal tissue trauma due to a monofilament design that reduces drag force by 2 to 3 times compared with braided absorbable sutures and a propriety polymer that utilizes a hydrolytic process to minimize tissue reaction during absorption.

Specifications

Suture Construction: Monofilament
Suture Color: Violet / Clear (undyed)
Available Sizes: 6/0 through 1
Suture BSR Profile (BSR=breaking strength retention (tensile strength of suture in vivo)):
Undyed (clear)           Dyed (violet)
1 week 50-60%                   60-70%
2 week 20-30%                 30-40%
Absorption complete by: 91-119 days

Vicryl - Polyglactin 910 suture

Overview

Coated Vicyrl Suture is a synthetic absorbable sterile surgical suture composed of a copolymer made from 90% glycolide and 10% L-lactide.
Coated Vicyrl Suture is indicated for use in general soft tissue approximation and/or ligation, including use in ophthalmic procedures, but not for use in cardiovascular and neurological tissues.

Description

Coated Vicyrl Suture is indicated for use in general soft tissue approximation and/or ligation, including use in ophthalmic procedures, but not for use in cardiovascular or neurological tissues.
This suture, being absorbable, should not be used where extended approximation of tissue is required.
Progressive loss of tensile strength and eventual absorption of Coated Vicyrl Suture occurs by means of hydrolysis. Absorption begins as a loss of tensile strength followed by a loss of mass.

Specifications

Suture Construction: Braided
Suture Color: Violet / White (undyed)
Available Sizes: 8/0 through 3
Suture BSR Profile (BSR=breaking strength retention (tensile strength of suture in vivo)):
2 weeks 75%
3 weeks 50%
4 weeks 25%
Absorption complete by: 56-70 days

Specifications

Suture Construction: Monofilament
Suture Color: Violet
Available Sizes: 10/0, 9/0
Suture BSR Profile (BSR=breaking strength retention (tensile strength of suture in vivo)):
2 weeks 75%
3 weeks 40%
Absorption complete by: 56-70 days

Vicryl Plus - Polyglactin 910 antibacterial suture

Overview

Coated Vicyrl Plus Suture is indicated for use in general soft tissue approximation and/ or ligation, except for ophthalmic, cardiovascular and neurological tissues.
Coated Vicyrl Plus Sutures provide multiple benefits.
Predictable breaking strength retention (BSR) profile to provide support for 14 to 28 days while tissues heal.
Shown in vitro to kill bacteria and inhibit bacterial colonization of the suture.
Proprietary suture coating and polymer properties minimize drag force and elicit only a slight tissue reaction during absorption.

Description

Coated Vicyrl Plus Sutures offer benefits in a range of surgical applications, including:
Predictable breaking strength retention (BSR) profile to provide support for 14 to 28 days while tissues heal
Provides protection against colonization of the suture by bacteria commonly associated with SSIs, including,
Staphylococcus aureus
Staphylococcus epidermidis
Methicillin-resistant Staphylococcus aureus (MRSA)
Methicillin-resistant Staphylococcus epidermidis (MRSE)
Smooth tissue passage, exceptional handling, and knot security
Multifilament design provides greater pliability than monofilament sutures and unsurpassed knot security.
Proprietary suture coating lowers tissue drag compared with standard braided sutures, and ensures easy knot sliding and knot positioning
Hydrolytic process elicits only a slight tissue reaction during absorption.

Specifications

Suture Construction: Braided
Suture Color: Violet / White (undyed)
Available Sizes: 5/0 through 2
Suture BSR Profile (BSR=breaking strength retention (tensile strength of suture in vivo)):
2 weeks 75%
3 weeks 50%
4 weeks 25%
Absorption complete by: 56-70 days

Specifications

Suture Construction: Monofilament
Suture Color: Violet
Available Sizes: 10/0, 9/0
Suture BSR Profile (BSR=breaking strength retention (tensile strength of suture in vivo)):
2 weeks 75%
3 weeks 40%
Absorption complete by: 56-70 days

PDS II - Polydioxanone suture

Overview

PDS II Sutures is prepared from the polyester, poly (p-dioxanone).
PDS II Sutures are indicated for use in soft tissue approximation, including use in pediatric cardiovascular tissue where growth is expected to occur and ophthalmic surgery. PDS II Suture is not indicated in adult cardiovascular tissue, microsurgery and neural tissue. These sutures are particularly useful where the combination of an absorbable suture and extended wound support (up to six weeks) is desirable

Description

PDS II Sutures are indicated for use in soft tissue approximation, including use in pediatric cardiovascular tissue where growth is expected to occur and ophthalmic surgery. PDS II Suture is not indicated in adult cardiovascular tissue, microsurgery and neural tissue.
PDS II Sutures, being absorbable, is not to be used where prolonged (beyond six weeks) approximation of tissues under stress is required and is not to be used in conjunction with prosthetic devices (i.e. heart valves or synthetic grafts).
PDS II Sutures have been formulated to minimize the variability of tensile strength retention and absorption rate (loss of mass) and to provide wound support through and extended healing period.

Specifications

Suture Construction: Monofilament
Suture Color: Violet / Clear (undyed)
Available Sizes: 7/0 through 2
Suture BSR Profile (BSR=breaking strength retention (tensile strength of suture in vivo)):
                 3/0 and larger      4/0 and smaller
2 weeks       80%                          60%
4 weeks       70%                          40%
6 weeks       60%                          35%
Absorption complete by: 182-238 days

PDS Plus - Polydioxanone antibacterial suture

Overview

Since fascial tissue heals slowly, fascial closure presents unique clinical challenges, such as the risk of dehiscence and infection. However, choosing the appropriate tool for fascial closure can help address known risk factors for these complications.
To create an environment that facilitates healing of the fascial tissue, sutures should:
Provide the strength to support the fascia and resist abdominal pressure through the critical healing period (14-28 days after surgery) and beyond.
Protect against colonization of the suture by organisms commonly associated with SSIs.
Pass smoothly through fascia to minimize tissue trauma
PDS Plus Sutures are specifically designed for secure fascial closure in multiple patient types:
Retains 60% of its original strength for 6 weeks, providing support to the fascia as it slowly heals
Shown in vitro to kill bacteria and inhibit bacterial colonization of the suture
Monofilament design and polymer properties minimize drag force and elicit only a slight tissue reaction during absorption.

Description

PDS Plus Sutures provide multiple benefits to address risk factors associated with dehiscence and infection in fascial closure, including:
Immediate support during the critical healing period (14 to 28 days) and extended support as the fascia slowly regains strength.
Protection against colonization of the suture by bacteria commonly associated with surgical site infections (SSIs), including:
Staphylococcus aureus
Staphylococcus epidermidis
Methicillin-resistant Staphylococcus aureus (MRSA)
Methicillin-resistant Staphylococcus epidermidis (MRSE)
Klebsiella pneumoniae
Escherichia coli
Propriety polymer that passes smoothly through tissue and utilizes a hydrolytic process to minimize tissue reaction during absorption.

Specifications

Suture Construction: Monofilament
Suture Color: Violet / Clear (undyed)
Available Sizes: 6/0 through 1
Suture BSR Profile (BSR=breaking strength retention (tensile strength of suture in vivo)):
                 3/0 and larger      4/0 and smaller
2 weeks       80%                          60%
4 weeks       70%                          40%
6 weeks       60%                          35%
Absorption complete by: 182-238 days